In silico toxicology protocols.
暂无分享,去创建一个
Tudor I. Oprea | Naomi L Kruhlak | Lidiya Stavitskaya | David Allen | Jean-Pierre Valentin | Romualdo Benigni | Barry Hardy | Patricia Ruiz | Véronique Gervais | Adam Woolley | David Woolley | Elena Lo Piparo | Rositsa Serafimova | Alexander Amberg | Steve Gutsell | Natalie Burden | Scott Miller | Marlene T Kim | Kevin P Cross | Masamitsu Honma | Nichola Gellatly | Grace Patlewicz | Tudor I Oprea | Marlene T. Kim | Andrea-Nicole Richarz | Susanne Glowienke | Andrew Teasdale | Glenn J Myatt | Ernst Ahlberg | Yumi Akahori | Lennart T Anger | Aynur Aptula | Scott Auerbach | Lisa Beilke | Phillip Bellion | Joel Bercu | Ewan D Booth | Dave Bower | Alessandro Brigo | Zoryana Cammerer | Mark T D Cronin | Laura Custer | Magdalena Dettwiler | Krista Dobo | Kevin A Ford | Marie C Fortin | Samantha E Gad-McDonald | Kyle P Glover | Jacky Van Gompel | James S Harvey | Jedd Hillegass | Jui-Hua Hsieh | Chia-Wen Hsu | Kathy Hughes | Candice Johnson | Robert Jolly | David Jones | Ray Kemper | Michelle O Kenyon | Sunil A Kulkarni | Klaus Kümmerer | Penny Leavitt | Bernhard Majer | Scott Masten | Janet Moser | Moiz Mumtaz | Wolfgang Muster | Louise Neilson | Alexandre Paulino | Mark Powley | Donald P Quigley | M Vijayaraj Reddy | Benoit Schilter | Wendy Simpson | Reinhard Stidl | Diana Suarez-Rodriguez | David T Szabo | Alejandra Trejo-Martin | Anna Vuorinen | Brian A Wall | Pete Watts | Angela T White | Joerg Wichard | Kristine L Witt | Craig Zwickl | Catrin Hasselgren | Donald P. Quigley | Krista L Dobo | T. Oprea | G. Myatt | S. Auerbach | G. Patlewicz | K. Cross | R. Benigni | W. Muster | A. Brigo | N. Kruhlak | M. Cronin | J. Hsieh | K. Witt | J. Wichard | M. Honma | S. Gutsell | S. Masten | M. Mumtaz | Chia-Wen Hsu | J. Valentin | R. Serafimova | W. Simpson | K. Kümmerer | B. Schilter | A. Aptula | David R. Jones | Ernst Ahlberg | V. Gervais | A. Vuorinen | N. Gellatly | N. Burden | S. Kulkarni | A. Amberg | R. Jolly | Kevin A. Ford | Elena Lo Piparo | A. Teasdale | J. Harvey | D. Bower | J. Bercu | A. Richarz | M. Kenyon | L. Stavitskaya | M. Powley | L. Anger | D. Allen | M. Fortin | M. V. Reddy | C. Johnson | Lisa Beilke | S. Glowienke | C. Hasselgren | J. Hillegass | Scott Miller | L. Neilson | Alexandre Paulino | R. Stidl | D. Szabo | B. Wall | Angela White | D. Woolley | C. Zwickl | E. Booth | P. Ruiz | K. Hughes | A. Woolley | Y. Akahori | J. van Gompel | K. Dobo | L. Custer | P. Bellion | D. Suarez-Rodriguez | Ray Kemper | B. Hardy | Alejandra Trejo-Martin | Samantha Gad-McDonald | P. Watts | Zoryana Cammerer | Penny Leavitt | Janet Moser | Kyle P. Glover | M. Dettwiler | B. Majer | James Harvey | M. Reddy
[1] M M Mumtaz,et al. A Weight-of-Evidence Approach for Assessing Interactions in Chemical Mixtures , 1992, Toxicology and industrial health.
[2] T W Schultz,et al. A strategy for structuring and reporting a read-across prediction of toxicity. , 2015, Regulatory toxicology and pharmacology : RTP.
[3] G Patlewicz,et al. Building scientific confidence in the development and evaluation of read-across. , 2015, Regulatory toxicology and pharmacology : RTP.
[4] R D Benz,et al. (Q)SAR Modeling and Safety Assessment in Regulatory Review , 2012, Clinical pharmacology and therapeutics.
[5] B. Schwetz,et al. Use of mechanistic and pharmacokinetic data for risk assessment at the National Institute of Environmental Health Sciences (NIEHS). , 1995, Toxicology letters.
[6] Bruno Hubesch,et al. Workshop: use of "read-across" for chemical safety assessment under REACH. , 2013, Regulatory toxicology and pharmacology : RTP.
[7] Nigel Greene,et al. In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: an industry survey. , 2012, Regulatory toxicology and pharmacology : RTP.
[8] Lisa Beilke,et al. In Silico Tools and their Application , 2017 .
[9] Andrew P. Worth,et al. The Integrated Use of Models for the Properties and Effects of Chemicals by means of a Structured Workflow , 2008 .
[10] Vinicius M. Alves,et al. Alarms about structural alerts. , 2016, Green chemistry : an international journal and green chemistry resource : GC.
[11] Nicholas Ball,et al. Use of category approaches, read-across and (Q)SAR: general considerations. , 2013, Regulatory toxicology and pharmacology : RTP.
[12] Andrew Teasdale,et al. ICH M7: Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk , 2017 .
[13] Alexander Amberg,et al. Do Carboxylic/Sulfonic Acid Halides Really Present a Mutagenic and Carcinogenic Risk as Impurities in Final Drug Products? , 2015 .
[14] A M Richard,et al. An automated curation procedure for addressing chemical errors and inconsistencies in public datasets used in QSAR modelling$ , 2016, SAR and QSAR in environmental research.
[15] Glenn J. Myatt,et al. CHAPTER 9:In silico Toxicology: An Overview of Toxicity Databases, Prediction Methodologies, and Expert Review , 2017 .
[16] Emilio Benfenati,et al. (Q)SAR tools for priority setting: A case study with printed paper and board food contact material substances. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[17] L. Theodore,et al. Toxic Substances Control Act (TSCA) , 2006 .
[18] John R. Bucher,et al. Systematic Review and Evidence Integration for Literature-Based Environmental Health Science Assessments , 2014, Environmental health perspectives.
[19] Jeanne Goshorn,et al. Selected Resources for Emergency and Disaster Preparedness and Response from the United States National Library of Medicine , 2008 .
[20] Ferran Sanz,et al. Applicability Domain Analysis (ADAN): A Robust Method for Assessing the Reliability of Drug Property Predictions , 2014, J. Chem. Inf. Model..
[21] Tian Zhang,et al. Development of quantitative structure activity relationship (QSAR) model for disinfection byproduct (DBP) research: A review of methods and resources. , 2015, Journal of hazardous materials.
[22] Andrew P Worth,et al. Validation of Computational Methods. , 2016, Advances in experimental medicine and biology.
[23] Marlene Ågerstrand,et al. Science in Risk Assessment and Policy (SciRAP): An Online Resource for Evaluating and Reporting In Vivo (Eco)Toxicity Studies , 2015 .
[24] Karen Blackburn,et al. A framework to facilitate consistent characterization of read across uncertainty. , 2014, Regulatory toxicology and pharmacology : RTP.
[25] Moiz Mumtaz,et al. Introduction to Mixtures Toxicology and Risk Assessment , 2010 .
[26] Vladimir B Bajic,et al. In silico toxicology: computational methods for the prediction of chemical toxicity , 2016, Wiley interdisciplinary reviews. Computational molecular science.
[27] Kevin A Ford,et al. Refinement, Reduction, and Replacement of Animal Toxicity Tests by Computational Methods. , 2016, ILAR journal.
[28] Steven J Enoch,et al. Adverse Outcome Pathway (AOP) Informed Modeling of Aquatic Toxicology: QSARs, Read-Across, and Interspecies Verification of Modes of Action. , 2016, Environmental science & technology.
[29] Scott D. Kahn,et al. Current Status of Methods for Defining the Applicability Domain of (Quantitative) Structure-Activity Relationships , 2005, Alternatives to laboratory animals : ATLA.
[30] Lidiya Stavitskaya,et al. Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses. , 2016, Regulatory toxicology and pharmacology : RTP.
[31] T M Martin,et al. Comparison of global and mode of action-based models for aquatic toxicity , 2015, SAR and QSAR in environmental research.
[32] N. Heinrich,et al. Computational Chemistry in the Pharmaceutical Industry: From Childhood to Adolescence , 2015, ChemMedChem.
[33] Andrew Teasdale,et al. Management of organic impurities in small molecule medicinal products: Deriving safe limits for use in early development , 2017, Regulatory toxicology and pharmacology : RTP.
[34] Karen Blackburn,et al. A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments. , 2010, Regulatory toxicology and pharmacology : RTP.
[35] Kathleen Stanton,et al. Quantifying the benefits of using read-across and in silico techniques to fulfill hazard data requirements for chemical categories. , 2016, Regulatory toxicology and pharmacology : RTP.
[36] Richard A Becker,et al. Read-across approaches--misconceptions, promises and challenges ahead. , 2014, ALTEX.
[37] Thomas Hartung,et al. "ToxRTool", a new tool to assess the reliability of toxicological data. , 2009, Toxicology letters.
[38] U. Tillmann,et al. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. , 1997, Regulatory toxicology and pharmacology : RTP.
[39] Klaus Kümmerer,et al. Designing green derivatives of β-blocker Metoprolol: a tiered approach for green and sustainable pharmacy and chemistry. , 2014, Chemosphere.
[40] Stephen W. Edwards,et al. Integrating Publicly Available Data to Generate Computationally Predicted Adverse Outcome Pathways for Fatty Liver. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.
[41] Andrew Worth,et al. Ab initio chemical safety assessment: A workflow based on exposure considerations and non-animal methods , 2017, Computational toxicology.
[42] Scott Boyer,et al. Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities. , 2013, Regulatory toxicology and pharmacology : RTP.
[43] J. Dearden,et al. QSAR modeling: where have you been? Where are you going to? , 2014, Journal of medicinal chemistry.
[44] Andrew Worth,et al. Establishing the level of safety concern for chemicals in food without the need for toxicity testing. , 2014, Regulatory toxicology and pharmacology : RTP.
[45] Mark W Powley,et al. (Q)SAR assessments of potentially mutagenic impurities: a regulatory perspective on the utility of expert knowledge and data submission. , 2015, Regulatory toxicology and pharmacology : RTP.
[46] M Verwei,et al. Development of a QSAR for worst case estimates of acute toxicity of chemically reactive compounds. , 2007, Toxicology letters.
[47] Raymond M Agius,et al. Progress with Structure–Activity Relationship modelling of occupational chemical respiratory sensitizers , 2017, Current opinion in allergy and clinical immunology.
[48] Alexandre Santos Aguiar,et al. Weight of evidence , 2008 .
[49] Lidiya Stavitskaya,et al. Establishing best practise in the application of expert review of mutagenicity under ICH M7. , 2015, Regulatory toxicology and pharmacology : RTP.
[50] Hao Zhu,et al. t4 report*: Toward Good Read-Across Practice (GRAP) Guidance , 2016, ALTEX.